Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

NCT00673179 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Low accrual.

Conditions

Osteosarcoma

Interventions

DRUG: Doxorubicin
DRUG: Cisplatin
DRUG: Methotrexate
DRUG: Leucovorin
DRUG: Dexrazoxane
DRUG: Ifosfamide
BEHAVIORAL: Questionnaire
DRUG: Gemcitabine
DRUG: Sargramostim
PROCEDURE: Surgery
DRUG: Mesna

Sponsor

M.D. Anderson Cancer Center